EX-10.1 2 v54779exv10w1.htm EX-10.1 exv10w1
Exhibit 10.1
MOTORCAR PARTS OF AMERICA, INC.
2929 California Street
Torrance, CA 90503
As of April 1, 2009
[*]
O’Reilly Automotive, Inc.
233 South Patterson
Springfield, MO 65802
Dear [*]:
O’Reilly Automotive, Inc. (together with its subsidiary entities, including CSK Auto, Inc., a wholly owned indirect subsidiary, “O’Reilly”) is engaged in the business of selling automotive parts and accessories, and Motorcar Parts of America, Inc. (“MPA”) is engaged in the business of manufacturing and selling alternators and starters for the automotive aftermarket. Representatives of O’Reilly and of MPA have had extensive discussions concerning O’Reilly’s needs with respect to MPA’s alternator and starter products and O’Reilly and MPA have reached an understanding effective as of the date of this letter (the “Effective Date”) with respect to their business, the terms of which are set forth in this letter Agreement (this “Agreement.”).
  1.   Other Agreements and Certain Arrangements:
  A.   O’Reilly and MPA are parties to a Vendor Agreement dated as of April 1, 2009 (together with any subsequent vendor agreements and amendments, the “Vendor Agreement.”). In the event of any inconsistency between this Agreement and the Vendor Agreement or any other agreement between O’Reilly and MPA, this Agreement, as it may be modified from time-to-time by a document making reference to this Agreement, shall control; provided however, that this Agreement does not supersede the rights O’Reilly may and the obligations MPA may have under the Vendor Agreement concerning product liability, defense and indemnification, and insurance protection. The parties agree that paragraphs 5, 9 and 10 of the Terms and Conditions applicable to the CSK Master Vendor Agreement dated December 14, 1998, as set forth on Schedule C to this Agreement, survive paragraph 1(B) of this Agreement with respect to all product heretofore sold by MPA to CSK Auto, Inc.
  B.   This Agreement supersedes all agreements between CSK and MPA and between O’Reilly and MPA, except as specifically set forth herein in paragraph 1(A). As a successor to CSK, O’Reilly is currently in possession of [*] with an agreed value of $[*] (the [*]).
  C.   MPA has credited the [*] payments due January and February 2009, in the amount of $[*].
 
[*] =   CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

1


 

  D.   Slotting fee agreements shall continue as currently exist with O’Reilly. Current agreements are listed below:
             
Program   Start Month   End Month   Total Due O’Reilly
Original [*]
  October 2003   October 2011   $[*]
2006 growth
  April 2006   March 2014   $[*]
2007 growth
  April 2007   March 2015   $[*]
2008 growth
  April 2008   March 2016   $[*]
2009 growth
  April 2009   March 2017   $[*]
      All amounts to be credited on a monthly basis. Remaining CSK [*] of $[*] is included in the 2009 growth figure of $[*].
  E.   Notwithstanding Section (A) above, the understandings between the parties with respect to the following (whether or not embodied in the form of a formal agreement) shall remain in effect:
             
Program   Start Month   End Month   Total Due O’Reilly
[*]
  June 2006   May 2011   $[*]
[*]
  January 2007   Oct 2011   $[*]
[*]
  August 2008   July 2009   $[*]
[*]
  January 2009   Dec 2013   $[*]
[*]
  April 2009   Mar 2019   $[*]
[*]
  June 2009   May 2014   $[*]
 
1   Domestic
 
*   All amounts to be credited on a monthly basis except [*] is credited on a quarterly basis.
  2.   Certain Definitions:
 
      As used herein, unless the context otherwise requires, the following terms shall have the meanings indicated:
  A.   “CSK” shall refer to CSK both before and after its acquisition by O’Reilly.
  B.   “Eligible Core Returns” are those cores in the then current MPA program that meet the standards for core returns currently existing between the parties and generally accepted in the industry and are returned in original MPA Ultima or Autolite boxes and Bosch and Beck/Arnley relabeled boxes, are rebuildable, have all component parts, part numbers and are not broken.
  C.   “Factoring Program” shall mean the factoring program with respect to O’Reilly accounts payable which had been in effect with Branch Banking & Trust Company through Spring 2008, or any program providing similar rights and obligations to the parties.
 
[*] =   CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

2


 

  D.   “Import” alternators and starters are alternators and starters used as original equipment on any vehicle, other than the following:
     
[*]   [*]
[*]   [*]
[*]   [*]
[*]   [*]
[*]   [*]
[*]   [*]
[*]   [*]
[*]   [*]
  E.   “Term of this Agreement” shall mean the period commencing April 1, 2009 and ending March 31, 2019.
  F.   “Unit Prices” shall mean the price for each alternator or starter (unit plus core) determined pursuant to this Agreement.
  G.   “Net Sale” shall mean sales net of core charges, warranty and other returns, net of stock adjustments and net of the allowance set forth in Paragraph 4 of this Agreement.
  H.   “Anticipated DC” or “Anticipated DC’s” shall mean one or more of [*].
  3.   [*] Requirements:
 
      During the Term of this Agreement, MPA shall be the [*]. In addition, domestic alternators and starters [*]. MPA must maintain [*] standards, perform in compliance with [*] standards and [*] for all units covered by this Agreement [*]. If MPA fails to maintain these standards, O’Reilly may, [*] [*] written notice of such failure. MPA will have [*] to cure to O’Reilly’s satisfaction. If MPA is not able to cure within the [*], O’Reilly, at its sole option and discretion, may terminate this Agreement by giving written notice thereof to MPA.
 
  4.   Pricing:
 
      MPA shall sell, on the terms described in Section 5 hereof, all alternators and starters at the current Unit Prices (unit plus core charges) which prices effective April 1, 2009 are set forth in Schedule A-1.
 
[*] =   CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

3


 

      After the initial [*] period immediately following the Effective Date of this Agreement, and upon the giving of [*] advance notice to O’Reilly, MPA may from time to time [*]. Nothing in this paragraph shall be read to diminish O’Reilly’s rights under paragraph 3 above.
 
      MPA shall contribute the following percentage amount and for the purposes indicated below, [*]:
 
      [*] - [*] Allowance;
 
      [*] - [*] Allowance;
 
      [*] - [*] Allowance includes setup, labor and inventory with the exception of the [*] stores. MPA shall supply setup and labor for [*] domestic and import product in new stores serviced from [*];
 
      [*] - [*] Fund;
 
      No less often than annually, O’Reilly shall furnish to MPA a list with such detail as MPA may reasonably request of all stores opened, acquired, relocated and closed by O’Reilly. In addition to those distribution centers described in paragraph 3 above, this Agreement also applies to new distribution centers opened during the term of this Agreement. With respect these new distribution centers, MPA shall grant O’Reilly with respect to each such new distribution center [*]. [*] shall be based upon the anticipated starter and alternator inventory at capacity of each such distribution center and shall be [*] beginning on the last day of the first month in which the distribution center is opened; [*] consistent with the terms set forth in Section 5 of this Agreement. New distribution center is defined as facilities opened after the agreement Effective Date not including Anticipated DC’s and not being a relocation of an existing facility.
 
  5.   Certain Sales and Credit Terms; Factoring:
 
      All sales shall be net payable to MPA, and credits due O’Reilly, [*] from O’Reilly receipt of shipment. All debits and credits shall be given in accordance with the usual practices of the parties, and shall be taken [*] from the date granted. MPA shall grant a further [*] [*] from net invoice to O’Reilly for payment within terms. All credits and allowances shall be taken as set forth in this Agreement, which supersedes the Vendor Agreement with respect to all matters contained herein, subject to paragraph 1(A) (D) & (E) above.
 
      O’Reilly agrees to use commercially reasonable efforts to again participate in a Factoring Program with respect to all of its payables related to this Agreement. MPA agrees to [*] day payment terms when the Factoring Program is reinstated at a mutually agreed
 
[*] =   CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

4


 

      discount rate. In the event the Factoring Program is reinstated, [*] would no longer apply. Additionally if a factoring program is utilized, [*].
 
  6.   [*]
 
      In partial consideration of this Agreement, MPA shall [*]. So long as this Agreement shall remain in effect and so long as MPA remains [*] commencing April 1, 2009 and continuing on the same day of each month thereafter until the amount is paid in full, March 1, 2016. This [*] includes [*]. Notwithstanding the foregoing, the [*] shall be earned ratably over a 120-month term of this Agreement. If this Agreement is terminated by O’Reilly [*].
 
      Should [*], the parties agree to [*].
 
  7.   Cores:
  A.   Except for the [*] as set forth in paragraph 1(B) of this Agreement, O’Reilly owns all [*] in its inventory on the Effective Date and, as set forth in this Agreement, O’Reilly shall own all [*] constituting part of the units delivered to O’Reilly hereunder after the Effective Date.
  B.   Each March 31 during the term of this Agreement (including March 31, 2009), [*] will [*]. The dollar amount by which the [*] exceeds [*]. If the [*] is less than [*]
 
[*] =   CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

5


 

      [*]. Schedule B contains [*].
  C.   From the time of receipt by O’Reilly to the time of shipment to MPA upon return, all risk of loss to [*] subject to this Agreement shall be with O’Reilly.
  D.   [*] shall remain the property of MPA and [*] shall be payable by O’Reilly to MPA only as set forth below. If MPA [*], O’Reilly shall [*]. After [*], MPA shall have no interest whatsoever in any [*] in O’Reilly’s inventory.
  8.   Confidentiality:
 
      O’Reilly and MPA shall not disclose the terms of this Agreement to any third parties other than (i) agents, accountants, attorneys or other representatives of either O’Reilly or MPA, as the case may be, on a “need to know” basis, or (ii) as required by law.
 
  9.   Notices:
 
      All notices, demands and other communications required, desired, or permitted to be given under this Agreement shall be in writing and shall be deemed to have been given immediately if personally delivered; twenty-four hours after being delivered to overnight delivery couriers or sent to telecopy, e-mail, or other electronic transmitting device, provided that the device records the date and time of successful transmission thereof; or five days after mailing by registered or certified mail, postage prepaid, return receipt requested, addressed in accordance with the addresses set forth below, or to such other addresses of which notice is given pursuant to this Section.
         
 
  If to O’Reilly:   O’Reilly Automotive, Inc.
 
      233 South Patterson
 
      Springfield, MO 65802
 
      Attn: [*]
 
      [*]
 
      Telephone: [*]
 
      Facsimile: [*]
 
      Email: [*]
 
       
 
  With copies to:   O’Reilly Automotive, Inc.
 
      233 South Patterson
 
      Springfield, MO 65802
 
      Attn: [*]
 
      [*]
 
      Telephone: [*]
 
[*] =   CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

6


 

         
 
      Fax: [*]
 
      Email: [*]
 
       
 
      -and-
 
       
 
      O’Reilly Automotive, Inc.
 
      233 South Patterson
 
      Springfield, MO 65802
 
      Attn: [*]
 
      [*]
 
      Telephone: [*]
 
      Fax: [*]
 
      Email: [*]
 
       
 
  If to MPA:   Motorcar Parts of America, Inc.
 
      2929 California Street
 
      Torrance, CA 90503
 
      Attn: Selwyn Joffe,
 
      Chairman, President & CEO
 
      Telephone: (310) 972-4005
 
      Facsimile: (310) 224-5128
 
      Email: sjoffe@motorcarparts.com
 
       
 
  With a copy to:   Motorcar Parts of America, Inc.
 
      2929 California Street
 
      Torrance, CA 90503
 
      Attn: Michael M. Umansky
 
      Vice President and General Counsel
 
      Telephone: (310) 972-4015
 
      Facsimile: (310) 943-1630
 
      Email: mumansky@motorcarparts.com
  10.   Entire Agreement:
 
      This Agreement contains the entire agreement between the parties with respect to the subject matter hereof and, unless otherwise noted herein, supersedes any prior agreements, arrangements, understandings, representations, warranties and covenants between the parties hereto. All other subject matters will continue to be governed by the O’Reilly vendor agreement.
 
  11.   Severability:
 
      If any portion of this Agreement is for any reason declared invalid or unenforceable by reason of any applicable law, the validity of the remaining portions shall not be affected thereby and such remaining portions shall remain in full force and effect as if this Agreement had been executed with the invalid portion eliminated.
 
[*] =   CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

7


 

  12.   Governing Law:
 
      This Agreement shall be governed by and construed in accordance with the internal laws of the State of Missouri in effect from time to time. Any litigation arising hereunder shall be brought in any court of competent subject matter jurisdiction located within the geographic boundary of Greene County, Missouri.
 
  13.   Attorneys’ Fees:
 
      In any litigation, to enforce or to interpret any part of this Agreement, the prevailing party shall be entitled to recover as an element of its costs of the action, all attorneys’ fees reasonably incurred in bringing such action and in enforcing any judgment or award granted therein, all of which shall be deemed to have accrued upon the commencement of such action.
 
  14.   Amendment:
 
      No supplement, amendment, or modification hereof shall be valid unless it shall be in writing and signed by all parties hereto.
 
  15.   Successors and Assigns:
 
      Except as otherwise specifically provided herein, all of the terms, provisions, and obligations of this Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective heirs, representatives, successors and assigns.
 
  16.   Further Assurances:
 
      Each party shall execute and deliver all such further instruments, documents or similar materials, and shall perform any and all acts necessary, to give full force and effect to all of the terms and provisions of this Agreement.
              IN WITNESS WHEREOF, the parties have caused this Agreement to be executed on the dates set forth opposite their names below.
         
O’REILLY AUTOMOTIVE, INC.    
 
       
By:
  [*]
 
   
 
       
ITS:
  [*]
 
   
 
       
Signature:
  [*]
 
   
 
       
Date:
  12/21/09
 
   
 
[*] =   CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

8


 

         
MOTORCAR PARTS OF AMERICA, INC.    
 
       
By:
  /s/ Selwyn Joffe
 
   
 
       
ITS:
  CEO    
 
       
Signature:
  /s/ Selwyn Joffe
 
   
 
Date:
  1/6/10    

9


 

Schedule A-1
[*]
 
[*] =   CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

10


 

O’Reilly MPA agreement Schedule A-1
                     
O’Reilly Part #   [*]   [*]   [*]
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]     $ [*] Adj effective 8/17/09
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]     $ [*] Adj effective 8/17/09
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]     $ [*] Adj effective 8/17/09
[*]
    [*]       [*]      
[*]
    [*]       [*]     $ [*] Adj effective 8/17/09
[*]
    [*]       [*]     $ [*] Adj effective 8/17/09
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]     $ [*] Adj effective 8/17/09
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]     $ [*] Adj effective 8/17/09
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]     $ [*] Adj effective 8/17/09
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]     $ [*] Adj effective 8/17/09
[*]
    [*]       [*]     $ [*] Adj effective 8/17/09
[*]
    [*]       [*]      
[*]
    [*]       [*]     $ [*] Adj effective 8/17/09
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
O’Reilly [*] Revised Schedule A-1
 
[*]  CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 1


 

O’Reilly MPA agreement Schedule A-1
                     
O’Reilly Part #   [*]   [*]   [*]
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
O’Reilly CSK [*] Revised Schedule A-1
 
[*]  CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 2


 

O’Reilly MPA agreement Schedule A-1
                     
O’Reilly Part #   [*]   [*]   [*]
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
O’Reilly CSK [*] Revised Schedule A-1
 
[*]  CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 3


 

O’Reilly MPA agreement Schedule A-1
                     
O’Reilly Part #   [*]   [*]   [*]
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]     $ [*] Adj effective 8/17/09
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
O’Reilly CSK [*] Revised Schedule A-1
 
[*]  CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 4


 

O’Reilly MPA agreement Schedule A-1
                     
O’Reilly Part #   [*]   [*]   [*]
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
O’Reilly CSK [*] Revised Schedule A-1
 
[*]  CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 5


 

O’Reilly MPA agreement Schedule A-1
                     
O’Reilly Part #   [*]   [*]   [*]
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
O’Reilly CSK [*] Revised Schedule A-1
 
[*]  CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 6


 

O’Reilly MPA agreement Schedule A-1
                     
O’Reilly Part #   [*]   [*]   [*]
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
O’Reilly CSK [*] Revised Schedule A-1
 
[*]  CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 7


 

O’Reilly MPA agreement Schedule A-1
                     
O’Reilly Part #   [*]   [*]   [*]
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]     $ [*] Adj effective 8/17/09
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
[*]
    [*]       [*]      
O’Reilly CSK [*] Revised Schedule A-1
 
[*]  CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 8


 

O’Reilly MPA agreement Schedule A-1
             
O’Reilly Part #   [*]   [*]   [*]
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*]  CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 9


 

O’Reilly MPA agreement Schedule A-1
           
O’Reilly Part # [*]   [*]   [*]
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*] =   CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 10


 

O’Reilly MPA agreement Schedule A-1
           
O’Reilly Part # [*]   [*]   [*]
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]   [*] Adj effective 8/17/09
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]   [*] Adj effective 8/17/09
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*] =   CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 11


 

O’Reilly MPA agreement Schedule A-1
           
O’Reilly Part # [*]   [*]   [*]
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*] =   CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 12


 

O’Reilly MPA agreement Schedule A-1
           
O’Reilly Part # [*]   [*]   [*]
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*] =   CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 13


 

O’Reilly MPA agreement Schedule A-1
           
O’Reilly Part # [*]   [*]   [*]
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*] =   CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 14


 

O’Reilly MPA agreement Schedule A-1
             
O’Reilly Part #   [*]   [*]   [*]
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*]  CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 15


 

O’Reilly MPA agreement Schedule A-1
             
O’Reilly part #   [*]   [*]   [*]
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*]  CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 16


 

O’Reilly MPA agreement Schedule A-1
             
O’Reilly part #   [*]   [*]   [*]
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]   [*] Adj effective 8/17/09
[*] [*]   [*]   [*] Adj effective 8/17/09
[*] [*]   [*]    
[*]     [*]   [*] Adj effective 8/17/09
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*]  CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 17


 

O’Reilly MPA agreement Schedule A-1
             
O’Reilly Part #   [*]   [*]   [*]
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
[*] [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*]  CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 18


 

O’Reilly MPA agreement Schedule A-1
             
O’Reilly Part #   [*]   [*]   [*]
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]   [*] Adj effective 8/17/09
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*]  CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 19


 

O’Reilly MPA agreement Schedule A-1
             
O’Reilly Part #   [*]   [*]   [*]
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*]  CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 20


 

O’Reilly MPA agreement Schedule A-1
             
O’Reilly Part #   [*]   [*]   [*]
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*]  CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 21


 

O’Reilly MPA agreement Schedule A-1
             
O’Reilly Part #   [*]   [*]   [*]
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*]  CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 22


 

O’Reilly MPA agreement Schedule A-1
             
O’Reilly Part #   [*]   [*]   [*]
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]       [*]   [*] Adj effective 8/17/09
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*]  CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 23


 

O’Reilly MPA agreement Schedule A-1
             
O’Reilly Part #   [*]   [*]   [*]
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*]  CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 24


 

O’Reilly MPA agreement Schedule A-1
             
O’Reilly Part #   [*]   [*]   [*]
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*]  CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 25


 

O’Reilly MPA agreement Schedule A-1
             
O’Reilly Part #   [*]   [*]   [*]
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*]  CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 26


 

O’Reilly MPA agreement Schedule A-1
             
O’Reilly Part #   [*]   [*]   [*]
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*]  CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 27


 

O’Reilly MPA agreement Schedule A-1
             
O’Reilly Part #   [*]   [*]   [*]
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*]  CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 28


 

O’Reilly MPA agreement Schedule A-1
             
O’Reilly Part #   [*]   [*]   [*]
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*]  CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 29


 

O’Reilly MPA agreement Schedule A-1
             
O’Reilly Part #   [*]   [*]   [*]
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*] = CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 30


 

O’Reilly MPA agreement Schedule A-1
             
O’Reilly Part #   [*]   [*]   [*]
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*]  = CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 31


 

O’Reilly MPA agreement Schedule A-1
             
O’Reilly Part #   [*]   [*]   [*]
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*]  = CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 32


 

O’Reilly MPA agreement Schedule A-1
             
O’Reilly Part #   [*]   [*]   [*]
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*]  = CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 33


 

O’Reilly MPA agreement Schedule A-1
             
O’Reilly Part #   [*]   [*]   [*]
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*]  = CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 34


 

O’Reilly MPA agreement Schedule A-1
             
O’Reilly Part #   [*]   [*]   [*]
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*] =   CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 35


 

O’Reilly MPA agreement Schedule A-1
             
O’Reilly Part #   [*]   [*]   [*]
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*] =   CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 36


 

O’Reilly MPA agreement Schedule A-1
             
O’Reilly Part #   [*]   [*]   [*]
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*] =   CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 37


 

O’Reilly MPA agreement Schedule A-1
             
O’Reilly Part #   [*]   [*]   [*]
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*] =   CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 38


 

O’Reilly MPA agreement Schedule A-1
             
O’Reilly Part #   [*]   [*]   [*]
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*] =   CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 39


 

O’Reilly MPA agreement Schedule A-1
             
O’Reilly Part #   [*]   [*]   [*]
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*] =   CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 40


 

O’Reilly MPA agreement Schedule A-1
             
O’Reilly Part #   [*]   [*]   [*]
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*]  =   CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 41


 

O’Reilly MPA agreement Schedule A-1
             
O’Reilly Part #   [*]   [*]   [*]
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*]  =   CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 42


 

O’Reilly MPA agreement Schedule A-1
             
O’Reilly Part #   [*]   [*]   [*]
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*]  =   CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 43


 

O’Reilly MPA agreement Schedule A-1
             
O’Reilly Part #   [*]   [*]   [*]
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
[*]   [*]   [*]    
O’Reilly CSK [*] Revised Schedule A-1
 
[*]  =   CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

Page 44


 

Schedule B
Calculation Examples With Respect to Paragraph 7 (B)
             
[*] (example balance March 31, 2009)
  [*]   [*]   Final balance to be determined
 
           
MPA owned CSK [*] as of March 31, 2009 [*] Less MPA owned CSK
  [*]   [*]   Prior to Feb 28, 2009 CSK Core Reconciliation
 
           
[*]
  [*]   [*]    
 
           
Prior Year [*] as of March 31, 2008
  [*]   [*]   [*]
 
           
Additional Support, net
  [*]   [*]    
 
           
Payable over [*] equal monthly credits
  [*]   [*]    
 
           
Additional monthly credit
  [*]   [*]    
(a) Detail includes the balance of all [*]
 
[*]  =   CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

11


 

SCHEDULE C
5.   Warranty.
 
    Vendor shall provide to CSK and its customers [*]. Vendor’s warranty against defective Product shall be administered as set forth on page 2 of this MVA. Except as otherwise specifically noted in this MVA, Vendor shall [*].
 
    Vendor warrants and guarantees except as authorized by CSK or as approved by past practice, that all Product furnished pursuant to this MVA and the packaging, labeling, labels and registration thereof and relating thereto: [*] In addition, Vendor warrants and guarantees that Vendor, to the extent required by law, has registered and is duly licensed to sell and distribute all such Product.
 
    Vendor warrants and represents that, as of the date of this MVA, Product may be lawfully sold in all locations where CSK conducts business except as otherwise listed on an attachment to this MVA, and that Vendor is unaware of any action by any governmental body in any location in which CSK conducts business to consider limiting or prohibiting the sale of any Product, except as listed on an attachment to this MVA. Vendor agrees to immediately inform CSK when it learns that any governmental body in any location in which CSK Conducts business is considering limiting or prohibiting the sale of any Product, except as listed on an attachment to this MVA. Prior to CSK buying any new Product from Vendor, Vendor will inform CSK if there is any location in which CSK does business in which the Product may not be sold, or in which a governmental body is considering limiting or prohibiting the sale of the Product. The foregoing warranties are in addition to any other representation and warranties, implied, or expressed that are set forth in the MVA, or which Vendor customarily supplies to purchasers of Product.
* * *
9.   Indemnification. Vendor agrees to indemnify and hold harmless CSK, its subsidiaries, parents, affiliates and their agents, directors, officers and employees (“indemnitee”) from any and all liability, loss or damage any Indemnitee may suffer as a result of
 
[*]  CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

12


 

    claims, demands, expenses, fees, fines, decrees, costs (including reasonable attorney’s fees), or judgments against any indemnitee (i) arising from the sale or exchange by CSK of any Product manufactured or distributed by Vendor which Product is defective in its design, repair, maintenance, distribution, labeling, manufacture or otherwise, or unfit for its intended purpose, or sale of such of which Product violates local ordinances or governmental regulations, (ii) arising directly and primarily out of any claim of infringement or other violation of any copyright, trade secrets, trademark, patent, invention, proprietary information, nondisclosure or other rights of any third party relating to Product, the packaging and/or advertising of Product, or to information supplied to CSK by Vendor, or (iii)arising from any breach of any provision of this MVA by Vendor.
 
    Vendor agrees to defend against any claims asserted or actions filed against any Indemnitee related or incident to the subject of the indemnity contained herein, whether such claims are rightfully or wrongfully brought or filed. If an action is brought or filed with respect to the subject of indemnity herein, Vendor agrees that CSK may employ attorneys of Vendor’s selections to appear and defend the claim or action on behalf of CSK (and at CSK’s option on behalf of any Indemnitee), at the reasonable expense of Vendor. CSK, at its option, shall have the sole authority for the direction of the defense, and shall be the sole judge of the acceptability of any compromise or settlement of any claims or actions against CSK or any Indemnitee, subject to written consent of vendor.
 
    CSK shall give written notice, of any Act or occurrence involving a liability, claim, demand, or item of cost indemnified against herein, as soon as reasonable practicable after the occurrence of such act or occurrence shall have come to CSK’s knowledge, provided that failure to give such notice shall not relieve Vendor of its obligation hereunder.
 
    This Paragraph 9 of the MVA shall continue in full force for one year following termination of this MVA, and shall remain binding upon Vendor notwithstanding that CSK and Vendor may have ceased any further business dealings. This Paragraph 9 shall not apply to the extent Vendor’s product liability insurance company fully and unconditionally accepts the tender of the defenses of any claim without limitation, and actually pays or reimburses all Indemnittees for all indemnified liability, loss, or damage each may suffer.
* * *
10.   Insurance. In addition to the indemnity provision stated herein, Vendor agrees to maintain general liability insurance (including Product liability insurance) during the term of the MVA, and for at least [*] hereafter that meets the following requirements:
  (a)   In an amount of no less than [*];
 
[*]  CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

13


 

  (b)   lists CSK Auto, Inc. and its parent, O’Reilly Automotive, Inc. as an additional insured; and
 
  (c)   Requires that CSK and O’Reilly be given [*] advance written notice of cancellation or modification of the policy.
      Within [*] of the execution of this MVA, and on each January 1 thereafter, Vendor shall provide to CSK at the address at the conclusion of this paragraph a Certificate of Insurance, stating the following: (a) “Certificate Holder is named as an additional insured for general liability and Product liability coverage, as their interests may appear”; (b) “Should any of the above described policies be cancelled before the expiration date thereof, the issuing company will mail [*] written notice to the certificate holder named to the left”; (c) Vendor has [*]; and (d) the Certificate Holder is: “CSK Auto, Inc., Attn: Merchandising Department (Vendor Certificate of Insurance), P.O. Box 6030, Phoenix, Arizona 85005”.
 
[*]  CONFIDENTIAL TREATMENT REQUESTED. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

14